Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Electrophysiological Guidance of Epidural Electrode Array Implantation over the Human Lumbosacral Spinal Cord to Enable Motor Function after Chronic Paralysis
Calvert, Jonathan S. , Grahn, Peter J. , Strommen, Jeffrey A., Lavrov, Igor , Gill, Megan L., Linde, Margaux B. , Straaten, Meegan G. Van , Veith, Daniel D. , Lopez, Cesar , Sayenko, Dimitry G. , Gerasimenko, Yury , Edgerton, V. Reggie , Zhao, Kristin D. , Lee, Kendall H. , Lavrov, Igor A, Brown, Desmond A., Van Straaten, Meegan G, Lavrov, Igor , Trentadue, Taylor P , Beck, Lisa A., Brown, Desmond , Sayenko, Dimitry G

Mayo Clinic

Journal of Neurotrauma | November 15, 2018 | Volume: 36 | Issue: 9 | Pages: 1451-1460

10.1089/neu.2018.5921 | PMID 30430902 Get It

Epidural electrical stimulation (EES) of the spinal cord has been shown to restore function after spinal cord injury (SCI). Characterization of EES-evoked motor responses has provided a basic understanding of spinal sensorimotor network activity related to EES-enabled motor activity of the lower extremities. However, the use of EES-evoked motor responses to guide EES system implantation over the spinal cord and their relation to post-operative EES-enabled function in humans with chronic paralysis attributed to SCI has yet to be described. Herein, we describe the surgical and intraoperative electrophysiological approach used, followed by initial EES-enabled results observed in 2 human subjects with motor complete paralysis who were enrolled in a clinical trial investigating the use of EES to enable motor functions after SCI. The 16-contact electrode array was initially positioned under fluoroscopic guidance. Then, EES-evoked motor responses were recorded from select leg muscles and displayed in real time to determine electrode array proximity to spinal cord regions associated with motor activity of the lower extremities. Acceptable array positioning was determined based on achievement of selective proximal or distal leg muscle activity, as well as bilateral muscle activation. Motor response latencies were not significantly different between intraoperative recordings and post-operative recordings, indicating that array positioning remained stable. Additionally, EES enabled intentional control of step-like activity in both subjects within the first 5 days of testing. These results suggest that the use of EES-evoked motor responses may guide intraoperative positioning of epidural electrodes to target spinal cord circuitry to enable motor functions after SCI.
Glioma response assessment: Classic pitfalls, novel confounders, and emerging imaging tools
Johnson, Derek R. , Ruff, Michael W. , Fang, Shanna, Morris, Pearse , Johnson, Derek R , Guérin, J. , Hunt, Christopher H. , Morris, Jonathan M. , Kaufmann, Timothy J.

Mayo Clinic

The British Journal of Radiology | November 9, 2018 | Volume: 92 | Issue: 1094 | Pages: 20180730

10.1259/bjr.20180730 | PMID 30412421 Get It

Diagnostic vs Management Reasoning—Reply
Cook, David A. , Sherbino, Jonathan , Durning, Steven J.

Mayo Clinic

JAMA | November 6, 2018 | Volume: 320 | Issue: 17 | Pages: 1818

10.1001/jama.2018.13358 | PMID 30398600 Get It

Obese Patients Benefit, but do not Fare as Well as Nonobese Patients, Following Lumbar Spondylolisthesis Surgery: An Analysis of the Quality Outcomes Database
Chan, Andrew K. , Bisson, Erica F. , Bydon, Mohamad , Glassman, Steven D. , Foley, Kevin T. , Potts, Eric A. , Shaffrey, Christopher I. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Park, Paul , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S, Kerezoudis, Panagiotis, DiGiorgio, Anthony M. , Haid, Regis W., Mummaneni, Praveen V. , Virk, Michael S, Kerezoudis, Panagiotis

Mayo Clinic

Neurosurgery | November 5, 2018 | Volume: 86 | Issue: 1 | Pages: 80-87

10.1093/neuros/nyy589 | PMID 30541141 Get It

Abstract BACKGROUND Given recent differing findings following 2 randomized clinical trials on degenerative lumbar spondylolisthesis (DLS) surgery, there is a need to better define how subsets of patients fare following surgery. OBJECTIVE To investigate the impact of obesity on patient-reported outcomes (PROs) following DLS surgery. METHODS A total of 12 high-enrolling sites were queried, and we found 797 patients undergoing surgery for grade 1 DLS. For univariate comparisons, patients were stratified by BMI ≥ 30 kg/m 2 (obese) and < 30 kg/m 2 (nonobese). Baseline, 3-mo, and 12-mo follow-up parameters were collected. PROs included the North American Spine Society satisfaction questionnaire, numeric rating scale (NRS) back pain, NRS leg pain, Oswestry Disability Index (ODI), and EuroQoL-5D (EQ-5D) Questionnaire. RESULTS We identified 382 obese (47.9%) and 415 nonobese patients (52.1%). At baseline, obese patients had worse NRS back pain, NRS leg pain, ODI, and EQ-5D scores ( P < .001, P = .01, P < .001, and P = .02, respectively). Both cohorts improved significantly for back and leg pain, ODI, and EQ-5D at 12 mo ( P < .001). At 12 mo, similar proportions of obese and nonobese patients responded that surgery met their expectations (62.6% vs 67.4%, P = .24). In multivariate analyses, BMI was independently associated with worse NRS leg pain and EQ-5D at 12 mo ( P = .01 and P < .01, respectively) despite adjusting for baseline differences. CONCLUSION Obesity is associated with inferior leg pain and quality of life—but similar back pain, disability, and satisfaction—12 mo postoperatively. However, obese patients achieve significant improvements in all PRO metrics at 12 mo.
DRES-20. THE TNF RECEPTOR FAMILY MEMBER Fn14 IS HIGHLY EXPRESSED IN RECURRENT GLIOBLASTOMA (GBM) AND IN GBM PATIENT-DERIVED XENOGRAFTS WITH ACQUIRED TEMOZOLOMIDE RESISTANCE
Heath, Jonathan E., Woodworth, Graeme F., Winkles, Jeffrey A. , Hersh, David S. , Tran, Nhan L. , Woodworth, Graeme F

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi79-vi80

10.1093/neuonc/noy148.327 Get It

NIMG-57. IMAGING FEATURES OF POLYMORPHOUS LOWGRADE NEUROEPITHELIAL TUMOR OF THE YOUNG (PLNTY)
Johnson, Derek R. , Giannini, Caterina , Kaufmann, Timothy J. , Morris, Jonathan M.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi189-vi189

10.1093/neuonc/noy148.783 Get It

Identifying high‐cost episodes in lower extremity joint replacement
Philpot, Lindsey M. , Swanson, Kristi M. , Inselman, Jonathan , Schoellkopf, William J., Naessens, James M. , Gladders, Barbara , Shah, Nilay D. , Ebbert, Jon O. , Borah, Bijan J. , Peterson, Stephanie, Ebbert, Jon O , Philpot, Lindsey M , Peterson, Stephanie

Mayo Clinic

Health Services Research | November 5, 2018 | Volume: 54 | Issue: 1 | Pages: 117-127

10.1111/1475-6773.13078 | PMID 30394529 Get It

ObjectivesTo evaluate the ability of claims‐based risk adjustment and incremental components of clinical data to identify 90‐day episode costs among lower extremity joint replacement (LEJR) patients according to the Centers for Medicare & Medicaid Services (CMS) Comprehensive Care for Joint Replacement (CJR) program provisions.Data SourcesMedicare fee‐for‐service (FFS) data for qualifying CJR episodes in the United States, and FFS data linked with clinical data from CJR‐qualifying LEJR episodes performed at High Value Healthcare Collaborative (HVHC) and Mayo Clinic in 2013. HVHC and Mayo Clinic populations are subsets of the total FFS population to assess the additive value of additional pieces of clinical data in correctly assigning patients to cost groups.Study DesignMultivariable logistic models identified high‐cost episodes.Data Collection/Extraction MethodsClinical data from participating health care systems merged with Medicare FFS data.Principal FindingsOur three populations consisted of 363 621 patients in the CMS population, 4881 in the HVHC population, and 918 in the Mayo population. When modeling per CJR specifications, we observed low to moderate model performance (CMS C‐Stat = 0.714; HVHC C‐Stat = 0.628; Mayo C‐Stat = 0.587). Adding CMS‐HCC categories improved identification of patients in the top 20% of episode costs (CMS C‐Stat = 0.758, HVHC C‐Stat = 0.692, Mayo C‐Stat = 0.677). Clinical variables, particularly functional status in the population for which this was available (Mayo C‐Stat = 0.783), improved ability to identify patients within cost groups.ConclusionsPolicy makers could use these findings to improve payment adjustments for bundled LEJR procedures and in consideration of new data elements for reimbursement.
CMET-47. CLINICAL EVALUATION OF FITNESS TO DRIVE IN PATIENTS WITH BRAIN METASTASES
Vora, Sujay A., Ashman, Jonathan B. , Daniels, T.B., Halyard, Michele Y. , Rule, William G., Butterfield, Richard , Sharma, Akanksha , Mrugala, Maciej , Porter, Alyx B. , Valencia-Sánchez, Cristina , Schild, Steven E. , Zhang, Nan

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi63-vi63

10.1093/neuonc/noy148.256 Get It

STEM-28. TISSUE FACTOR PROMOTES THE GLIOMA STEM CELL PHENOTYPE, AND IS SUPPRESSED BY MUTANT IDH1
Mirkov, Snezana, Wray, Brian, Lamano, Jonathan B., James, C. David , Unruh, Dusten , Scholtens, Denise M. , Sarkaria, Jann N. , Horbinski, Craig

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi249-vi249

10.1093/neuonc/noy148.1035 Get It

Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients
Woolley, Susan , Goetz, Ray, Factor‐Litvak, Pam , Murphy, Jennifer , Hupf, Jonathan , Lomen‐Hoerth, Catherine , Andrews, Howard , Heitzman, Daragh, Bedlack, Richard , Katz, Jonathan, Barohn, Richard J., Sorenson, Eric J. , Oskarsson, Björn , Filho, Americo Fernandes, Kasarskis, Edward J. , Mozaffar, Tahseen , Nations, Sharon , Swenson, Andrea , Koczon-Jaremko, Agnes, Christodoulou, Georgia , Mitsumoto, Hiroshi , Garofalo, Diana C. , Sorenson, Eric, Oskarsson, Björn , Bedlack, Richard S , Christodoulou, Georgia

Mayo Clinic

Behavioural Neurology | October 31, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-7

10.1155/2018/5969137 | PMID 30515252 Get It

Objective. To evaluate longitudinal cognitive/behavioral change over 12 months in participants enrolled in the ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS). Methods. We analyzed data from 294 ALS participants, 134 of whom were studied serially. Change over time was evaluated controlling for age, sex, symptom duration, education, race, and ethnicity. Using multiple regression, we evaluated associations among decline in ALS Functional Rating Scale-Revised (ALSFRS-R) scores, forced vital capacity (FVC), and cognitive/behavioral changes. Change in cognitive/behavioral subgroups was assessed using one-way analyses of covariance. Results. Participants with follow-up data had fewer baseline behavior problems compared to patients without follow-up data. We found significant worsening of behavior (ALS Cognitive Behavioral Screen (ALS CBS) behavioral scale, p<0.001; Frontal Behavioral Inventory-ALS (FBI-ALS) disinhibition subscale, p=0.044). Item analysis suggested change in frustration tolerance, insight, mental rigidity, and interests (p<0.05). Changes in ALSFRS-R correlated with the ALS CBS. Worsening disinhibition (FBI-ALS) did not correlate with ALSFRS-R, FVC, or disease duration. Conclusion. We did not detect cognitive change. Behavioral change was detected, and increased disinhibition was found among patients with abnormal baseline behavioral scores. Disinhibition changes did not correlate with disease duration or progression. Baseline behavioral problems were associated with advanced, rapidly progressive disease and study attrition.